<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03545555</url>
  </required_header>
  <id_info>
    <org_study_id>AGBAP2018-1</org_study_id>
    <nct_id>NCT03545555</nct_id>
  </id_info>
  <brief_title>Investigations on the Effect of Kale on the Lipid Status</brief_title>
  <acronym>HypocholKale</acronym>
  <official_title>Investigations on the Effect of Kale on the Lipid Status (Untersuchungen Zum Einfluss Von Grünkohl Auf Den Lipidstatus)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Jena</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Jena</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This intervention study investigates the effects of various kale preparations (dietary
      supplements) on lipid status parameters. Within the study period of 8 weeks, three blood
      withdrawals are planned (week 0, 4 and 8) for the volunteers. Lipid status parameters (total
      cholesterol, HDL cholesterol, LDL cholesterol, triacylglycerides) will be determined in
      blood. There is a correlation between contents of LDL cholesterol, total cholesterol and
      triacylglycerides and the risk for cardiovascular diseases (CVD). In contrast, a high content
      of HDL cholesterol is correlated with a lower risk for CVD. In addition, the contents of
      apolipoprotein A1 and apolipoprotein B will be analysed.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 13, 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of lipid status parameters</measure>
    <time_frame>weeks 0, 4 and 8</time_frame>
    <description>total cholesterol, HDL cholesterol, LDL cholesterol</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of apolipoproteins</measure>
    <time_frame>weeks 0, 4 and 8</time_frame>
    <description>apolipoprotein A1 and apolipoprotein B</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of antioxidant capacity</measure>
    <time_frame>weeks 0, 4 and 8</time_frame>
    <description>lipophilic antioxidant capacity (L-TEAC)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Effects of Kale Ingredients on Lipid Status Parameter</condition>
  <arm_group>
    <arm_group_label>Kale Powder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 capsules with kale preparation &quot;kale powder&quot; per day for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Kale Extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 capsules with kale preparation &quot;kale extract&quot; per day for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Flavonoid Extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 capsules with kale preparation &quot;flavonoid extract&quot; (from kale) per day for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>5 capsules with &quot;placebo&quot; per day for 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Kale Preparation &quot;Kale Powder&quot;</intervention_name>
    <description>Effect of kale preparation kale powder on lipid status</description>
    <arm_group_label>Kale Powder</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Kale Preparation &quot;Kale Extract&quot;</intervention_name>
    <description>Effect of kale preparation kale extract on lipid status</description>
    <arm_group_label>Kale Extract</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Kale Preparation &quot;Flavonoid Extract&quot;</intervention_name>
    <description>Effect of kale preparation flavonoid extract on lipid status</description>
    <arm_group_label>Flavonoid Extract</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Effect of placebo on lipid status</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  total cholesterol &gt; 200 mg/dl

        Exclusion Criteria:

          -  LDL cholesterol &lt; 130 mg/dl

          -  medication to lower blood lipids

          -  genetically based hypercholesterolemia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Volker Böhm, PD Dr.</last_name>
    <phone>+49-(0)3641-9496</phone>
    <phone_ext>33</phone_ext>
    <email>Volker.Boehm@uni-jena.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Friedrich Schiller University, Institute iof Nutritional Science</name>
      <address>
        <city>Jena</city>
        <state>Thuringia</state>
        <zip>07743</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Volker Boehm, PD Dr.</last_name>
      <phone>+(49)3641/949633</phone>
      <email>volker.boehm@uni-jena.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>May 7, 2018</study_first_submitted>
  <study_first_submitted_qc>May 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2018</study_first_posted>
  <last_update_submitted>May 22, 2018</last_update_submitted>
  <last_update_submitted_qc>May 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Jena</investigator_affiliation>
    <investigator_full_name>Volker Boehm</investigator_full_name>
    <investigator_title>Head of Bioactive Plant Products Research Group</investigator_title>
  </responsible_party>
  <keyword>kale</keyword>
  <keyword>antioxidant capacity</keyword>
  <keyword>cholesterol</keyword>
  <keyword>lipid status</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

